Kim, Y., Lee, J. Y., Kim, C. G., Park, B., Park, J. Y., & Choi, I. J. (2021). Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: A randomized open-label trial. BMC Gastroenterol.

Kim, Young-Il, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Jin Young Park, و Il Ju Choi. "Ten-day Bismuth-containing Quadruple Therapy Versus 7-day Proton Pump Inhibitor-clarithromycin Containing Triple Therapy As First-line Empirical Therapy for the Helicobacter Pylori Infection in Korea: A Randomized Open-label Trial." BMC Gastroenterol 2021.

Kim, Young-Il, et al. "Ten-day Bismuth-containing Quadruple Therapy Versus 7-day Proton Pump Inhibitor-clarithromycin Containing Triple Therapy As First-line Empirical Therapy for the Helicobacter Pylori Infection in Korea: A Randomized Open-label Trial." BMC Gastroenterol 2021.